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Background. Genital ulcer disease (GUD) is commonly caused by pathogens for which suitable therapies exist,
but clinical and laboratory diagnoses may be problematic. This collaborative project was undertaken to address
the need for a rapid, economical, and sensitive approach to the detection and diagnosis of GUD using noninvasive
techniques to sample genital ulcers.
Methods. The genital ulcer disease multiplex polymerase chain reaction (GUMP) was developed as an inhouse
nucleic acid amplification technique targeting serious causes of GUD, namely, herpes simplex viruses (HSVs), Hae-
mophilus ducreyi, Treponema pallidum, and Klebsiella species. In addition, the GUMP assay included an endogenous
internal control. Amplification products from GUMP were detected by enzyme linked amplicon hybridization assay
(ELAHA).
Results. GUMP-ELAHA was sensitive and specific in detecting a target microbe in 34.3% of specimens,
including 1 detection of HSV-1, three detections of HSV-2, and 18 detections of T. pallidum. No H. ducreyi has
been detected in Australia since 1998, and none was detected here. No Calymmatobacterium (Klebsiella) granulomatis
was detected in the study, but there were 3 detections during ongoing diagnostic use of GUMP-ELAHA in 2004
and 2005. The presence of C. granulomatis was confirmed by restriction enzyme digestion and nucleotide sequencing
of the 16S rRNA gene for phylogenetic analysis.
Conclusions. GUMP-ELAHA permitted comprehensive detection of common and rare causes of GUD and
incorporated noninvasive sampling techniques. Data obtained by using GUMP-ELAHA will aid specific treatment
of GUD and better define the prevalence of each microbe among at-risk populations with a view to the eradication
of chancroid and donovanosis in Australia.
Genital ulcer disease (GUD) is commonly caused by
pathogens against which suitable therapies exist but for
which clinical and laboratory diagnoses may be prob-
lematic. The 3 most common etiological agents of gen-
ital lesions are the herpes simplex viruses (HSVs), Trep-
onema pallidum subspecies pallidum (a gram-negative
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bacterium that causes syphilis), and Haemophilus du-
creyi (a gram-negative bacteria that causes chancroid).
Although chancroid has not been reported in Australia
since 1998, the total number of Australian notifications
of syphilis have ranged from 1304 notifications in 1997
to 2056 in 2004 [21].
An additional but rare cause of GUD is the gram-
negative organism traditionally entitled Calymmato-
bacterium granulomatis. Further characterization of the
organism by cell culture [8, 14] and DNA sequencing
resulted in the proposed reclassification of the organism
to Klebsiella granulomatis [5, 9]. The disease has been
commonly known as granuloma inguinale, but the pre-
ferred name, donovanosis, is less limiting when de-
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scribing the potential of the disease to affect many anatomical
sites, resulting in chronic, ulcerative disease [4]. Although it is
generally a benign infection, disease can result in extensive
tissue destruction and can even be fatal [13]. Donovanosis is
endemic in parts of Southern Africa, Brazil, India, Papua New
Guinea, the Caribbean, and Central and Northern Australia,
including the north of Western Australia [13, 22]. Despite that
the number of Australian donovanosis notifications decreased
from 117 in 1994 to 16 in 2002 and 2003 [21], clinical under-
diagnosis of the condition, in addition to the reluctance of per-
sons to present for treatment, is suspected of falsely depressing
prevalence figures [3, 16]. The detection of donovan bodies
within large mononuclear cells obtained in smears of lesion or
biopsy material remains the conclusive diagnostic approach, re-
quiring careful specimen selection and expert histological inves-
tigation [13].
PCR has improved the speed and sensitivity of microbial
diagnosis and permitted more-common use of less invasive
sampling techniques [6, 23]. Multiplex PCR makes best use of
limited amounts of clinical material when multiple targets are
under investigation, and it improves cost-effectiveness [27]. C.
(Klebsiella) granulomatis has not been included in previously
reported multiplex PCR assays investigating GUD, despite the
existence of a robust PCR technique [7, 10].
We report the first single-tube, multiplex PCR to simulta-
neously detect 5 microbial agents of GUD together with an en-
dogenous internal control included to determine any effects on
amplification caused by inhibitors or degraded template. This
collaborative project was undertaken to address the need for a
rapid, economical, and sensitive approach to the detection and
diagnosis of treatable GUD using noninvasive sampling tech-
niques. The intent of the application of the genital ulcer disease
multiplex PCR (GUMP) assay was also to improve understanding
of the prevalence of donovanosis in at-risk populations and test
the hypothesis that Queensland is chancroid free.
METHODS AND MATERIALS
Clinical specimens. To perform a prospective study of the
multiplex PCR, 64 specimens consisting of smear and/or press
slides ( ), swabs ( ), and tissue biopsies ( )np 3 np 59 np 2
were collected. The specimens, as part of routine clinical care,
were supplied without detailed clinical histories, but it is known
that they were collected from 55 HIV-uninfected subjects
(58.9% of whom were male) presenting at remote area health
centers in northern Queensland with any acute or chronic gen-
ital lesion during 2002. Subjects were not excluded on the basis
of previous or ongoing antimicrobial therapy. The subject pop-
ulation predominantly comprised Aborigines and Torres Strait
Islanders who ranged in age from 2.6 years to 59.4 years, with
a median age of 24.8 years. Results were compared with those
of conventional testing, including PCR, bacterial and viral cul-
ture, histologic analysis, rapid plasmin reagin (RPR) and Ve-
nereal Disease Research Laboratory assays, T. pallidum particle
agglutination (TPPA), and fluorescent treponemal antibody ab-
sorption. Nucleic acids were purified from 200 mL of each
resuspended specimen using the High Pure PCR Template
Preparation Kit (Roche Diagnostics).
PCR. Multiplex PCR combined 5 mL of synthetic control
or purified specimen with 45 mL of PCR mix (4 mM of MgCl2;
50 mM of KCl; 10 mM of Tris-HCl [pH, 8.3]; 0.2 mM of dATP,
dCTP, and dGTP; 0.4 mM of dUTP; and 3 mM of digoxigenin-
11-dUTP [Boehringer Mannheim]) containing 2 pmol of each
oligonucleotide primer (Sigma-Genosys) (table 1) and 2 units
of PlatinumTaq DNA polymerase (Invitrogen). The primers for
HSV, H. ducreyi and T. pallidum were chosen from a previous
study [23], whereas the primers for C. granulomatis were unique
to this study. Amplification commenced with a 2-min incu-
bation at 95C followed by 45 cycles of 20 s at 94C, 20 s at
62C, and 30 s at 72C and a final 7-min incubation at 72C.
Uniplex PCR containing template DNA was performed as
described for multiplex PCR, except only a single primer pair
corresponding to 1 target sequence was included. Confirmatory
PCR assays were employed for discrepant results for HSV and
T. pallidum by targeting the polymerase and 16S rRNA genes,
respectively [18, 26].
Amplicon was detected by agarose gel electrophoresis or by
enzyme linked amplicon hybridization assay (ELAHA), a mi-
crowell DNA hybridization method using an enzyme-mediated
color reaction to indicate the presence of specific template am-
plification [19].
Construction of synthetic controls. Positive controls con-
taining cloned templates were assembled for each target, as
described elsewhere [19]. Templates were obtained from clinical
material. Each primer pair’s amplicon was electrophoresed, pu-
rified (QIAquick gel extraction kit; Qiagen), and ligated into
the pGEM-T Easy Vector System I (Promega). Plasmids con-
taining the insert were transformed into Escherichia coli DH5a
and expanded in culture, and 1 mL of the transformed bacteria
was directly screened by PCR-ELAHA. Positive clones were
purified using a mini-prep purification kit (GenElute Plasmid
Miniprep Kit; Sigma). The controls were designated pWCtpal
(T. pallidum subspecies pallidum), pWCcg (C. granulomatis),
pWChsv1, pWChsv2, pWChd (H. ducreyi), and pWCerv (en-
dogenous retrovirus 3).
Synthetic control stocks were initially quantified at 260 nm
using a UV visible spectrometer (Cintra 20; GBC) then titrated
using 10-fold dilutions from 107 to 100 copies/mL. Each dilution
was tested by uniplex PCR to confirm the expected copy num-
ber, as described elsewhere [18]. Quantified stock solutions
containing adjusted copy numbers in the range of to91 10
amplifiable targets were stored in 2-mL single-use ali-95 10
quots at 70C.
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Table 1. Nucleotide sequences and origin of the sense and antisense primers and biotinylated oligoprobes,
together with the expected amplicon length.
Oligonucleotide Oligonucleotide sequence (5′– 3′) Target gene
Amplicon length
(base pair) Reference
HSV01.16a GCCGTAAAACGGGGACATGTACACAAAGT Glycoprotein B 432 [23]
HSV02.16 TTCAAGGCCACCATGTACTACAAAGACGT
HSV1_P01.162 GCGTTGGCCGGTTTCAGCTCC … … This study
HSV2_P02.16 GACCTTCGCCGGCTTGAGCTC
HD01.1 CAAGTCGAACGGTAGCACGAAG HD 16S rRNA 439 [23]
HD02.1 TTCTGTGACTAACGTCAATCAATTTTG
HD_P02.1 CCGAAGGTCCCACCCTTTAATCCGA
TPAL01.3 CAGAGCCATCAGCCCTTTTCA 47kDa lipoprotein 260 [23]
TPAL02.3 GAAGTTTGTCCCAGTTGCGGTT
TPAL_P01.3 CGGGCTCTCCATGCTGCTTACCTTA
ERV01.1 CATGGGAAGCAAGGGAACTAATG Envelope 136 [29]
ERV02.1 CCCCAGCGAGCAATACAGAATT
ERV_P01.3 TCTTCCCTCGAACCTGCACCATCAAGTCA
CG01.1 TCCTCTGCCCAGACCGATAACTTTATG phoE 328 This study
CG02.1 CCAGGTAGATATTGTTGGCGTCA
CG_P01.1 GCCGTCAGCGCAGCCTACACCAGC
16SrRNA01.1 CCTAACACATGCAAGTCGA Bacterial 16S rRNA 556 [9]
16SrRNA01.2 CGGTCTGTCAAGTCGGAT
16SrRNA02.1 ATCCGACTTGACAGACCG … 653 …
16SrRNA02.2 TGTAGCACGTGTGTAGCC
NOTE. CG, Calymmatobacterium granulomatis; ERV, endogenous retrovirus 3; HD, Haemophilus ducreyi; HSV, herpes simplex virus;
TPAL, Treponema pallidum.
1 Forward (01.X) and reverse (02.X) primers.
2 Oligonucleotide probe is identified by the “P” preceding the 3 digit identification number.
C. (Klebsiella) granulomatis confirmation. Confirmation
of C. granulomatis among Klebsiella-positive specimens was
performed by digesting the amplicon with 5 units of HaeIII
(Promega) in a total volume of 20 mL (figure 1).
Further confirmation of the presence of C. granulomatis re-
quired amplification of the 16S rRNA gene using primers 16S
rRNA 01.1 and 02.1 (table 1) [9]. Both strands of amplicon
representing ∼500 bases proximal to the 5′ end of the gene were
sequenced (ABI PRISM BigDye v3.1; Perkin Elmer Applied
Biosystems Division).
RESULTS
Analytical sensitivity and assay specificity. ELAHA increased
the limit of amplicon detection by at least 8-fold, compared
with agarose gel electrophoresis of an equal amount of ampli-
con (data not shown) [18]. GUMP-ELAHA was capable of
detecting copies of each synthetic control template per03 10
50-mL reaction, or, when all 6 templates, including the internal
control, were coamplified, GUMP-ELAHA was capable of de-
tecting copies per reaction (table 2). In addition, all13 10
coamplified template loads above the limit of detection could
be visualized using agarose gel electrophoresis and discrimi-
nated by ELAHA (data not shown).
A wide range of related and unrelated nucleic acid templates
were investigated by GUMP-ELAHA, including Bacillus later-
osporus, Bartonella henselae, Citrobacter freundii, Citrobacter ko-
seri, Cryptococcus neoformans, Klebsiella pneumoniae, Klebsiella
oxytoca, Klebsiella oxzanae, Klebsiella planticola, Enterobacter
aerogenes, Enterobacter agglomerans, Enterobacter cloacae, E. coli,
Escherichia fergunosii, Enterococcus faecalis, Enterococcus fae-
cium, Enterococcus durans, Salmonella species, Streptococcus spe-
cies, Serratia species, Saccharomyces cerevisiae, Candida species,
Vibrio alginolyticus, Flavobacterium multivoram, Shigella flex-
neri, Proteus species, Staphylococcus species, Neisseria menin-
gitidis, Acinetobacter haemolyticus, Bacillus coagulans, and hu-
man genomic DNA (Promega). The only GUMP primer pair
to crossreact with an unintended template was that for the
detection of C. granulomatis, which amplified some entero-
bacterial non-GUMP targets.
The GUMP study. A GUMP target was identified in 22
specimens (34.3%), comprising 4 HSV specimens (6.2%) and
18 T. pallidum specimens (28.1%), whereas 42 (65.6%) of the
64 specimens remained negative for a target by GUMP-ELAHA
(table 3). Twenty specimens (31.2%) were negative for a target
by both GUMP-ELAHA and traditional testing. There were 4
instances in which HSV-2 was detected by culture but not by
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Figure 1. The expected restriction enzyme patterns resulting from
HaeIII restriction of the 328–base pair (bp) phosphate porin (phoE) am-
plicon generated by amplification of Klebsiella templates using genital
ulcer disease multiplex polymerase chain reaction (primer sites are boxed).
The 167-bp fragment (A) was diagnostic for Calymmatobacterium gran-
ulomatis and was absent when unintended bacterial species were am-
plified and restricted. B, The Klebsiella rhinoscleromatis sequence is pre-
sented as an example of a nontarget species of Klebsiella.
Table 2. Results of genital ulcer disease multiplex PCR sensi-
tivity studies using multiplex PCR reactions and synthetic tem-
plates either individually or in a coamplified pool.
Target
Copies per reaction
3 (3100) 30 (3101) 300 (3102)
pWChsv1
Single template + + +
Pooled template  + +
pWChsv2
Single template + + +
Pooled template + + +
pWCtpal
Single template + + +
Pooled template  + +
pWChd
Single template + + +
Pooled template + + +
pWCcg
Single template + + +
Pooled template  + +
NOTE. +, Positive amplification; , negative amplification.
GUMP-ELAHA: in 1 instance, HSV-2 was detected by the con-
firmatory assay; in another instance, detection was affected by
amplification failure; and in the remaining 2 instances, the
specimens originated from the same subject and repeatedly
tested negative by both HSV assays. To further examine the
performance of the HSV component of GUMP-ELAHA, 103
previously determined HSV-positive and HSV-negative swab
specimens (50 were HSV negative, 24 were HSV-1 positive, 26
were HSV-2 positive, and 3 were dual HSV positive) were ex-
amined, and the results demonstrated that the HSV component
of GUMP-ELAHA was capable of an analytical sensitivity of
98.2% and a specificity of 96.1%. No subjects were found to
be positive for either H. ducreyi or C. granulomatis. Of the 11
subjects who were negative for T. pallidum by the GUMP-
ELAHA assay but positive for antibody elicited by treponemal
infection, 8 had previous clinical diagnoses of syphilis. Ac-
counting for the new information increased the sensitivity and
specificity values of the T. pallidum component (table 3; values
are in square brackets). No previous results or relevant clinical
histories were available for the remaining 4 subjects. No dual
infections were detected among the GUMP targets; however, a
total of 8 subjects contained indications of 2 microbes in their
specimens. Three subjects were positive for Chlamydia tra-
chomatis and T. pallidum; 2 subjects were positive for C. tra-
chomatis and Neisseria gonorrhoeae; 2 subjects were positive for
T. pallidum and HSV-2; and 1 subject was positive for T. pal-
lidum and N. gonorrhoeae.
In all but 3 (5.0%) of the subject specimens tested, the en-
dogenous internal control template was amplifiable. Clinically,
the failure of the endogenous internal control only affected the
diagnostic outcome of 2 (3.3%) of the study specimens, because
one of the endogenous retrovirus–negative samples was positive
for a pathogen.
C. (Klebsiella) granulomatis confirmatory assays. The C.
granulomatis PCR primers yielded a 328 base pair amplicon
from C. granulomatis and other Klebsiella species, including K.
pneumoniae, K. oxytoca species, and K. planticola, and from
some E. coli strains. Discrimination of these from true C. gran-
ulomatis templates was achieved by generating a diagnostic 167–
base pair fragment following restriction of the amplicon with
HaeIII (figure 2). No C. granulomatis was detected during the
prospective study period; however, ongoing use of GUMP de-
tected C. granulomatis in 1 instance during 2004 and in 2
instances during 2005 from clinically diagnosed subjects. DNA
sequencing of a fragment of the 16S rRNA gene of the 3 strains
confirmed that they shared 100% of their nucleotide sequence
identities. Their nearest homologues were C. granulomatis
(99.5% identity) and Klebsiella rhinoscleromatis (99.3% iden-
tity). Phylogenetic analysis confirmed these associations, dem-
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Table 3. Results of the genital ulcer disease multiplex PCR (GUMP)–enzyme linked amplicon hybridization assay (ELAHA) study and
























HSV-1 1 (1) 0 63 (54) 0 100 100 100 100
HSV-2 3 (3) 4 (3) 57 (49) 1  Treponema pallidum
RPR 1  T. pallidum
TPPA+/RPR
64 100 100 93
T. pallidum 18 (14) 11 (11) 35 (30) 3  Chlamydia
trachomatis
70 [86] 93 [94] 90 [86] 78 [94]
Haemophilus ducreyi 0 (0) 0 (0) 64 (55) NA NA NA NA NA
Calymmatobacterium
granulomatis 0 (0) 0 (0) 64 (55) NA NA NA NA NA
NOTE. T. pallidum assay performance values, adjusted for previous diagnoses, are listed in square brackets. Calculations were performed using specimen
numbers. Sensitivity p [traditional assay positives / (traditional assay positives + GUMP negatives)]. Specificityp [traditional assay negatives / (traditional assay
negatives + GUMP positives)]. Positive-predictive valuep [(traditional assay positives / (traditional assay positives + GUMP positives)]. Negative-predictive value
p [(traditional assay negatives / (traditional assay negatives + GUMP negatives)]. HSV, herpes simplex virus; NA, not applicable; RPR, rapid plasmin reagin; TPPA,
T. pallidum particle agglutination.
onstrating branching patterns similar to those described else-
where (figure 3) [5, 9].
DISCUSSION
The GUMP assay was developed to detect sexually transmitted
ulcerating agents among at-risk Australian populations, with a
view to expediting the eradication of these diseases from Aus-
tralia. The assay is currently in restricted use in Northern
Queensland, which resulted in 3 instances in which C. gran-
ulomatis was detected, confirming that donovanosis remains in
some parts of Australia. The lack of H. ducreyi detections sug-
gest that chancroid is uncommon among our subjects; however,
testing a larger specimen population will be required to translate
this suggestion to the broader target community.
GUMP-ELAHA proved to be sensitive, even when all 5 mi-
crobial templates were coamplified; however, it is extremely
unlikely that this would occur in a clinical environment. Our
expanded assay retained identical analytical sensitivity to the
multiplex PCR described by Orle et al. [23], on which GUMP-
ELAHA was founded. Primers used in the assay used by Orle
and colleagues were further validated by use in India, Thailand,
and Lesotho [1, 20, 24]. The improvements to sensitivity and
specificity brokered by the ELAHA satisfactorily balanced the
addition of primers to detect C. granulomatis and an endog-
enous retrovirus–3 target serving as an endogenous internal
control. Additionally, because GUMP is capable of codetecting
a range of templates at a range of concentrations from a single
reaction, it follows that clinical samples that are strongly pos-
itive for a single microbial template do not require further
investigation to ensure that competitive PCR conditions have
not masked the amplification of a second or third target.
Our study included, for the first time in a multiplex PCR
assay to detect agents of GUD, an endogenous internal control
to monitor template quality and purification efficiency. Am-
plification failure occurred for 5.0% of all specimens. This was
similar to previous reports of diagnostic PCR failure [2, 11, 17,
25, 28]. Nonetheless, only 3% of the field trial results were
adversely affected, which was less than that reported by Orle
et al. [23], and we assumed that PCR inhibition or template
degradation was the cause of these failures. Additional speci-
mens were not available to permit re-extraction of endogenous
internal control–negative material.
The analyses of sensitivity and specificity data for the T.
pallidum component of the assay were affected by the nature
of the conventional testing methods and a paucity of detailed
clinical histories. Lesion swabs were the specimen type of choice
for the GUMP assay to detect microbes at the site of infection;
however, traditional testing for syphilis principally relied on
serological assays, which detect a nonspecific immune response
to recent, previous, and systemic treponemal infection.
The T. pallidum primers theoretically amplify other members
of the T. pallidum species, because of their genetic similarities;
however, the nonvenereal disease associated with these other
treponemes is uncommon in Australia and generally responds
to the therapies used to treat syphilis. The C. granulomatis
component of the multiplex PCR was the source of the only
proven unintended amplification observed during use of
GUMP-ELAHA. Nonetheless, restriction-enzyme digestion and
nucleotide sequencing adequately discriminated between C.
granulomatis and genetically similar bacteria. Diagnostic am-
plification of C. granulomatis DNA by PCR was first described
in an article in 1999 by Carter et al. [7], in which the phoE
(phosphate porin) gene was targeted . This assay was comple-
mented by nucleotide sequencing to identify 2 unique base
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Figure 2. Agarose gel electrophoresis of Klebsiella species and suspected Calymmatobacterium granulomatis amplicon before and after HaeIII
restriction digestion. Lane 1, 100–base pair (bp) DNA molecular weight marker; lanes 2 and 3, Escherichia coli amplicon following and preceding
restriction digestion, respectively; lanes 4 and 5, Klebsiella pneumoniae amplicon following and preceding restriction digestion, respectively; lanes 6
and 7, Calymmatobacterium granulomatis amplicon following and preceding restriction digestion, respectively.
changes in C. granulomatis that eliminated HaeIII restriction
sites and differentiated this bacterium from other members of
the Enterobacteriaceae family. Whereas Carter et al. [7, 10] used
known positive biopsy samples to validate PCR sensitivity, to-
gether with a small number of genital swabs obtained from
patients with other conditions to check specificity, we applied
a synthetic control and examined DNA from numerous related
microorganisms to extend the assay validation data, particularly
for H. ducreyi and C. granulomatis, for which limited positive
clinical material was available. Limited sequence data is publicly
available for C. granulomatis strains; therefore, future studies
should aim to sequence the phoE target to ensure the stability
of the nucleotide polymorphism over time and around the
world. Should the mutation prove to be a reliable target, a real-
time PCR assay capable of discriminating the polymorphism
should prove to be a useful and significantly more rapid di-
agnostic tool. Three suspected clinical cases of donovanosis
were confirmed by GUMP-ELAHA and by restriction, indi-
cating that the relevant polymorphism remains stable in Aus-
tralia. Phylogenetic analysis of 16S rRNA gene sequencing in-
dicated that the 3 Australian strains were most closely related
to C. granulomatis. Restriction of the amplicon proved to be
the most rapid confirmatory assay, whereas nucleotide sequenc-
ing was not essential for routine confirmation.
The GUMP study detected the presence of a target microbe
in 34% of specimens provided to our laboratory. By compar-
ison, traditional PCR, culture, and serological testing were able
to identify at least 1 pathogen in 67% of specimens (64% of
patients). Other studies report that more than one-third of
specimens have negative results in multiplex PCR studies; how-
ever, the etiology of GUD in different study regions may vary
dramatically, making comparison with our population difficult
[6, 20, 24]. The disparity between GUMP-ELAHA and tradi-
tional results can be largely explained by the inclusion C. tra-
chomatis and N. gonorrhoeae PCR and culture testing, in ad-
dition to the use of traditional serological assays that
overdiagnosed T. pallidum infections; indeed, on retrospective
analysis of the available diagnostic data, it was found that some
subjects in this study had been previously diagnosed with syph-
ilis. It is likely that these circulating antibodies contributed to
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Figure 3. Phylogenetic analysis of suspected Calymmatobacterium (Klebsiella) granulomatis strains detected in Queensland (Q) during 2004 and
2005, presented on a topology tree prepared using Molecular Evolutionary Genetics Analysis 3 software [15] (GenBank accession numbers DQ112321-
3). A 490–base pair 16S rRNA nucleotide alignment comprising Queensland strains together with other related and unrelated bacteria was prepared
using BioEdit software, version 7.0. The nucleotide distance matrix was generated using the Kimura 2-parameter estimation. Nodal confidence values
indicate the results of boot strap resampling ( ). Accession numbers for sequences obtained from GenBank are shown.np 1000
a positive serodiagnosis, despite the absence of treponemes at
the lesion site, as indicated by a negative GUMP result. Similar
problems have been reported by Orle et al. [20], who proposed
that treponemal serologic testing could lead to overdiagnosis
of primary syphilis, reflecting its insensitive and nonspecific
nature. The sensitivity and rapidity of GUMP-ELAHA could
prove that it is especially useful for early identification of pri-
mary syphilis, whereas indirect RPR, fluorescent treponemal
antibody absorption, TPPA, and Venereal Disease Research Lab-
oratory assays can take weeks to be of diagnostic value. Sim-
ilarly, Chen et al. [12] demonstrated no concordance between
H. ducreyi serologic testing and PCR. Because GUMP-ELAHA
was intended to detect microbial nucleic acids at the site of an
active lesion, similar to the function of fluorescent microscopy,
detailed comparison of the PCR with serological treponemal
testing is largely unwarranted. However, the role of serological
assays is important, because they provide an indication of the
history of treponemal infection among persons with previous
exposure; thus, serologic testing should continue to be used in
conjunction with GUMP-ELAHA. We believe that the number
of diagnoses could be further increased if complete clinical
histories were available to address the relatively low number of
HSV detections in our study. An unidentifiable number of the
study subjects were suffering from recurring or persistent GUD
and had been tested previously for HSV and subsequently pre-
scribed treatment. Therefore, the overall likelihood that HSV
could be detected among the GUMP study population was
reduced, compared with other studies. A separate validation of
the HSV component of GUMP-ELAHA demonstrated high
sensitivity and specificity, reinforcing that presampling thera-
pies could have been responsible for the reduced number of
HSV detections. The GUMP population contained a total of 8
codetections; however, the severity of disease associated with
suspected multiple infections could not be inferred from the
data.
We have described a single-tube multiplex PCR assay to di-
agnose common and rare causes of GUD. GUMP performed
with high sensitivity and was more rapid and more objective
than conventional assays, including culture and fluorescent an-
tibody techniques, for the direct detection of all targets. Ad-
ditional applications of GUMP-ELAHA would benefit from a
longer-term study of the role of PCR versus traditional testing
among a larger and better-defined study population. Nonethe-
less, decreased turnaround times for results should permit ear-
lier and more appropriate treatment of disease, whereas the
less invasive nature of the sampling techniques should en-
courage more subjects to present for diagnosis of ulcerated
lesions, thus improving our understanding of the epidemiology
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of these diseases and helping us to focus our efforts to eradicate
them.
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